Title : Biweekly cetuximab plus FOLFIRI/irinotecan as first/second-line chemotherapy for patients with KRAS wild-type metastatic colorectal cancer: a retrospective analysis in Southwest Chinese population.

Pub. Date : 2014 May

PMID : 24683007






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Biweekly cetuximab plus FOLFIRI/irinotecan as first/second-line chemotherapy for patients with KRAS wild-type metastatic colorectal cancer: a retrospective analysis in Southwest Chinese population. FOLFIRI regimen KRAS proto-oncogene, GTPase Homo sapiens